Charlotte

Our finance lawyers represent major industry players in structuring, securitizing, managing and servicing complex and highly structured and securitized commercial real estate debt assets.

We advise issuers, underwriters, collateral managers, investment-grade and B piece investors in CMBS, Re-REMICs, NPLs and other alternate securitized structures involving commercial real estate and residential mortgages. We advise on collateralized loan obligation transactions and in offerings of both traditional and esoteric asset-backed securities.

In addition, we advise bankers and other capital sources on the acquisition, structuring, financing, sale and syndication or securitization of large complex loans and on the purchase, sale and financing of loan pools.

Dechert has been at the forefront of advising private equity firms for 40 years and ranked among the top law firms for U.S. and Global PE Buyouts and Global M&A by Bloomberg, Mergermarket and Refinitiv. With more than 350 private equity and private investment clients, we have unique insights into how the industry has evolved and where it’s going next. Our global team advises private equity, private credit and other alternative asset managers on flexible solutions at every phase of the investment life cycle.

Dechert’s life sciences industry group delivers industry expertise and commercial judgment to help leading life sciences and healthcare companies navigate their most complex and demanding transactional, intellectual property and litigation matters. Our global multi-disciplinary team has the reach, resources and experience to provide comprehensive transactional, regulatory and dispute resolution services anywhere in the world.

Dechert helps clients comply with the many, often inconsistent, rules and regulations established to protect the privacy of customer and employee information while minimizing the cost and time for compliance. We have particular expertise advising clients on cybersecurity and data protection in the financial services, consumer marketing, healthcare and life sciences sectors.

We represent private funds and their managers on a variety of transactions, from advising start-up managers operating a limited number of strategies to publicly traded global financial institutions and their affiliates. We also help managers develop strategies within more retail-based vehicles, including exchange-traded funds and UCITS.